Search research articles
Contact Us
Filters
Showing results (61-70 of 381) with videos related to
Page
of 39
Sort By:
Cancers
|
December 1, 2020
Risk and Response-Adapted Treatment in Multiple Myeloma
Titouan Cazaubiel, Olga Mulas, Lydia Montes, et al.
Haematologica
|
November 9, 2004
Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients
Patrice Chevallier, Nelly Robillard, Soraya Wuilleme-Toumi, et al.
Journal De Chirurgie
|
December 1, 1995
[Abdominal lymphomas in children: place of surgery]
Y Héloury, F Méchinaud-Lacroix, V Plattner, et al.
Cancer
|
April 1, 1995
Morphologic and molecular cytogenetics in neuroblastoma
H Avet-Loiseau, A M Venuat, J Benard, et al.
Leukemia
|
October 26, 2011
Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents
B Mohty, J El-Cheikh, I Yakoub-Agha, et al.
Leukemia Research
|
September 5, 2007
CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis
Régis Bataille, Catherine Pellat-Deceunynck, Nelly Robillard, et al.
Leukemia
|
July 29, 2000
Expression of cyclins D-type in B-chronic lymphoproliferative disorders
B Sola, G Roué, F Duquesne, et al.
Medical and Pediatric Oncology
|
June 1, 1996
Rothmund-Thomson syndrome and osteosarcoma
I Cumin, J Y Cohen, A David, et al.
European Journal of Immunology
|
February 11, 2025
NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial
Marine Villard, Sébastien Viel, Lionel Karlin, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Cyclin D1 expression in patients with multiple myeloma
X Troussard, H Avet-Loiseau, M Macro, et al.
Page
of 39
Search research articles
Search
Showing results (61-70 of 381) with videos related to
Sort By:
Page
of 39
Cancers
|
December 1, 2020
Risk and Response-Adapted Treatment in Multiple Myeloma
Titouan Cazaubiel, Olga Mulas, Lydia Montes, et al.
Haematologica
|
November 9, 2004
Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients
Patrice Chevallier, Nelly Robillard, Soraya Wuilleme-Toumi, et al.
Journal De Chirurgie
|
December 1, 1995
[Abdominal lymphomas in children: place of surgery]
Y Héloury, F Méchinaud-Lacroix, V Plattner, et al.
Cancer
|
April 1, 1995
Morphologic and molecular cytogenetics in neuroblastoma
H Avet-Loiseau, A M Venuat, J Benard, et al.
Leukemia
|
October 26, 2011
Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents
B Mohty, J El-Cheikh, I Yakoub-Agha, et al.
Leukemia Research
|
September 5, 2007
CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis
Régis Bataille, Catherine Pellat-Deceunynck, Nelly Robillard, et al.
Leukemia
|
July 29, 2000
Expression of cyclins D-type in B-chronic lymphoproliferative disorders
B Sola, G Roué, F Duquesne, et al.
Medical and Pediatric Oncology
|
June 1, 1996
Rothmund-Thomson syndrome and osteosarcoma
I Cumin, J Y Cohen, A David, et al.
European Journal of Immunology
|
February 11, 2025
NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial
Marine Villard, Sébastien Viel, Lionel Karlin, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Cyclin D1 expression in patients with multiple myeloma
X Troussard, H Avet-Loiseau, M Macro, et al.
Page
of 39